The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization

Ellen R Klinkert, Frank J. Broekmans, Caspar W.N. Looman, J. Dik F. Habbema, Egbert R. te Velde
In: Fertility and Sterility · 2005 · vol. 83(3) , pp. 811–814 · doi:10.1016/j.fertnstert.2004.11.005 · PMID:15749527 · W2105596856
article OA: bronze CC0 ⤵ 1 in-corpus citation
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study compared the predictive value of antral follicle count versus basal follicle-stimulating hormone for IVF success in older women, finding antral follicle count to be a superior marker.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Cited by (1)

References (23)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK